NCT00984360View on ClinicalTrials.gov

Study of Naltrexone for Methamphetamine Addiction

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

September 30, 2012

Conditions
Methamphetamine Dependence
Interventions
DRUG

Naltrexone

380mg extended-release, given once by intramuscular gluteal injection

Trial Locations (1)

94110

Addiction & Pharmacology Research Laboratory, San Francisco

Sponsors
All Listed Sponsors
lead

California Pacific Medical Center Research Institute

OTHER